Ozari vs Sequence: An Honest Comparison of GLP-1 Telehealth Options

If you're researching GLP-1 medications for weight loss, you've likely come across both Ozari Health and Sequence. Both are telehealth companies that connect you with providers who can prescribe medications like semaglutide and tirzepatide. But the similarities end there. Understanding the differences in cost, medication sources, and approach can help you make the right choice for your health journey.

What Both Companies Offer

Let's start with common ground. Both Ozari and Sequence provide access to GLP-1 medications through telemedicine platforms. That means no in-person doctor visits required. You'll complete an online assessment, connect with a licensed healthcare provider, and if appropriate, receive a prescription.

Both companies serve patients across the United States and handle the logistics of getting medication to your door. They also both offer semaglutide and tirzepatide, the two most effective GLP-1 medications for weight management.

That's where the similarities end.

The Cost Difference: What You'll Actually Pay

This is where things get interesting, and honestly, it's probably why you're reading this article.

Ozari Health offers compounded semaglutide and tirzepatide starting at $99 per month. This straightforward pricing includes your medication, provider consultations, and ongoing support.

Sequence's pricing structure is more complex. They primarily offer brand-name medications like Wegovy and Zepbound, which can cost significantly more—often $1,000 or more per month without insurance. While Sequence does work with insurance when possible, coverage for weight loss medications remains limited for many people.

Sequence has recently begun offering compounded options at lower price points, but their pricing still tends to be higher than Ozari's transparent $99 starting point.

Understanding Compounded vs Brand-Name

Here's something important to understand: compounded medications contain the same active ingredients as brand-name versions. They're prepared by licensed pharmacies according to FDA guidelines, just not manufactured by the original pharmaceutical company.

For many people, compounded GLP-1 medications offer an accessible entry point to treatment that would otherwise be financially out of reach. The active ingredient—semaglutide or tirzepatide—works the same way in your body whether it's compounded or brand-name.

Medication Options and Availability

Ozari specializes in compounded semaglutide and tirzepatide. This focus allows them to keep costs predictable and accessible. You'll work with your provider to determine which medication and dosage is right for you, with the flexibility to adjust as needed.

Sequence offers both brand-name and compounded options. If you have insurance coverage for brand-name medications like Wegovy or Zepbound, Sequence may help you navigate that process. However, most patients end up paying out-of-pocket, which brings us back to the cost consideration.

The Care Experience

Both platforms connect you with licensed healthcare providers, but the experience differs slightly.

Ozari emphasizes a streamlined, doctor-forward approach. You'll complete an assessment, consult with a physician, and receive ongoing support through their platform. The focus is on making GLP-1 therapy accessible without unnecessary complexity.

Sequence offers a more comprehensive platform with additional features like nutritional guidance and community support. For some people, these extras are valuable. For others, they're features they won't use but may be paying for indirectly.

What About Ongoing Support?

Starting a GLP-1 medication is just the beginning. You'll likely have questions about side effects, dosing adjustments, and what to expect as you progress.

Both companies offer ongoing access to healthcare providers. Ozari includes this in your monthly fee. With Sequence, the level of support may vary depending on which plan tier you select.

Who Each Option Works Best For

Ozari Health is ideal if you're looking for straightforward, affordable access to GLP-1 medications without insurance complications. It's designed for people who want effective treatment at a predictable monthly cost.

Sequence might be worth considering if you have robust insurance coverage for brand-name weight loss medications or if you specifically want the additional platform features they offer. Just be prepared for potentially higher costs.

A Note on Gender Differences

Women often face unique considerations with GLP-1 therapy, including questions about hormonal birth control interactions and family planning. Both platforms should address these concerns, but it's worth asking specific questions during your consultation. Women also tend to experience nausea more frequently than men when starting these medications, so having responsive provider support matters.

Making Your Decision

Choosing a GLP-1 telehealth provider comes down to three main factors: cost, medication preference, and the type of support you want.

If transparent pricing and accessibility are your priorities, Ozari's $99 starting point is hard to beat. If you have specific insurance coverage or want brand-name medications regardless of cost, Sequence offers that path.

Both are legitimate companies with licensed providers. The question isn't which is "better" in absolute terms—it's which better fits your specific situation and budget.

Remember, the best GLP-1 program is the one you can afford to stay on long enough to see results. Consistency matters more than perfection.

From the Ozari Care Team

One of the most common mistakes we see is patients stopping GLP-1 therapy too soon because of cost concerns. Starting at a dose you can sustain financially is more effective than beginning with an expensive option you can't maintain. The medication works when taken consistently over time, not in sporadic bursts.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026